Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sonninen

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1981
[Subacute cerebellar degeneration]L Paljärvi, V Sonninen
Acta Neurologica Scandinavica|January 1, 1970
Catecholamines in Parkinson's diseaseU K Rinne, V Sonninen
Neurology|January 1, 1972
Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's diseaseU K Rinne, V Sonninen
Archives of Neurology|February 1, 1973
Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitorU K Rinne, V Sonninen
European Neurology|January 1, 1987
Hereditary multi-infarct dementiaV Sonninen, M L Savontaus
Clinical Neurology and Neurosurgery|January 1, 1975
Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlationsT Siirtola, V Sonninen, U K Rinne
Zeitschrift Fur Neurologie|January 1, 1972
Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitorU K Rinne, V Sonninen, T Sirtola
European Neurology|January 1, 1972
Treatment of Parkinson's disease with amantadine and L-DopaU K Rinne, V Sonninen, T Siirtola
Headache|July 1, 1972
Excretion of free and conjugated 5-HIAA and VMA in urine and concentration of 5-HIAA and HVA in CSF during migraine attacks and free intervalsP Kangasniemi, V Sonninen, U K Rinne
Acta Neurologica Scandinavica|January 1, 1970
L-dopa treatment in Parkinson's diseaseU K Rinne, V Sonninen, T Sürtola
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1981
[Subacute cerebellar degeneration]L Paljärvi, V Sonninen
Acta Neurologica Scandinavica|January 1, 1970
Catecholamines in Parkinson's diseaseU K Rinne, V Sonninen
Neurology|January 1, 1972
Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's diseaseU K Rinne, V Sonninen
Archives of Neurology|February 1, 1973
Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitorU K Rinne, V Sonninen
European Neurology|January 1, 1987
Hereditary multi-infarct dementiaV Sonninen, M L Savontaus
Clinical Neurology and Neurosurgery|January 1, 1975
Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlationsT Siirtola, V Sonninen, U K Rinne
Zeitschrift Fur Neurologie|January 1, 1972
Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitorU K Rinne, V Sonninen, T Sirtola
European Neurology|January 1, 1972
Treatment of Parkinson's disease with amantadine and L-DopaU K Rinne, V Sonninen, T Siirtola
Headache|July 1, 1972
Excretion of free and conjugated 5-HIAA and VMA in urine and concentration of 5-HIAA and HVA in CSF during migraine attacks and free intervalsP Kangasniemi, V Sonninen, U K Rinne
Acta Neurologica Scandinavica|January 1, 1970
L-dopa treatment in Parkinson's diseaseU K Rinne, V Sonninen, T Sürtola
Pageof 5